Speaker Profile
Director of Business, VPIX Medical
Biography
Heejoon Um is an experienced innovator in the field of medical technology, known for driving progress at the intersection of real-time diagnostics and surgical care. With a deep understanding of global healthcare systems, he has spearheaded international expansion strategies and clinical collaborations across North America, Europe, and Asia. Heejoon has played a central role in bringing disruptive imaging technologies to market, improving surgical precision and patient outcomes. He actively engages with key opinion leaders, regulatory experts, and industry stakeholders to accelerate the adoption of transformative solutions. Recognized for his strategic insight and cross-cultural expertise, Heejoon continues to build bridges between cutting-edge science and clinical application, reshaping the future of intraoperative Imaging.
Talk
The Role of Intraoperative Histopathologyduring Cancer Surgery
This talk will introduce VPIX Medicals real-time imaging platform, cCeLL, which delivers intraoperative histopathology without frozen sections. By enabling immediate, high-resolution cellular visualization at the surgical site, cCeLL enhances intraoperative decision-making, improves margin assessment, and supports maximal safe resection across a range of tumor types.
Clinical Dx Showcase:
VPIX Medical
VPIX Medical is a medical device company specializing in real-time, in vivo histopathology imaging. Its flagship platform, cCeLL, enables surgeons to visualize cellular structures during surgery, enhancing diagnostic precision and improving surgical outcomes.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2025 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
